Eye infection is caused by bacteria, micro-organisms, viruses, and fungi that invade any part of the eye ball and surrounding area which include inner eyelids (conjunctiva), the thin, moist membrane lining the outer eye, and the front surface of the eye (cornea). Eye infections can be the inflammation of the eyelid (blepharitis), conjunctiva (conjunctivitis), the liquid inside the eye (vitritis), the cornea (keratitis), the optic nerve (neuroretinitis) or the retina and the blood vessels that feed it (chorioretinitis). There are numerous symptoms of eye infection such as redness of eyes, pain, light sensitivity, watery eyes, swelling around the eyes, itching of eyes, blurry vision, swollen eyes, and dry eyes.

There are different types of eye infections such as conjunctivitis also known as pink eyes. This infection or inflammation affects the conjunctiva, which is the transparent, thin tissue that covers the external surface of the eye. Endophthalmitis causes inflammation in the intraocular cavity of the eye, including involvement of the vitreous and/or aqueous humour. Endophthalmitis can be chronic (months to years after intraocular surgery), endogenous or post-traumatic (penetrating or perforating ocular injuries). Keratitis is an infection of the cornea that can be caused by Acanthamoeba (a microscopic, waterborne parasite) or the bacteria Staphylococcus aureus and Pseudomonas aeruginosa. Toxoplasmosis of the eye is inflammation of the retina and choroid. Trachoma is one of the leading causes of preventable blindness worldwide. Trachoma is caused by bacterium Chlamydia trachomatis, and leads to repeated conjunctivitis and a mucous discharge. It reduces tears production and causes difficulty in closing the eyelids. This disease is linked to developing countries, due to poor hygiene and crowded living conditions.

The eye infection treatment market is set to expand with the sudden increase in diagnosis and prevalence rate of eye diseases. The market for eye infection treatment is segmented on the basis of product type, distribution channel, and region. Based on product type, the market is majorly segmented as eye drops, gels & creams, and drugs. The drugs segment is further classified into antibiotics, anti-inflammatory, lubricants, and anti-allergens. The generic, low cost competition for some of the drugs and rising prevalence and early diagnosis of eye infections is likely to boost the market in future. Poor personal hygiene

Based on distribution channel, the eye infection treatment market is segmented into hospital pharmacies, retail pharmacies, and E-commerce. Retail pharmacies and hospital pharmacies hold the major share of the eye infection treatment market globally.

Based on geography, the global eye infection treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Geographically, North America was observed to have the largest share of the eye infection treatment market due to better healthcare awareness, high prevalence of disease, and high rate of diagnosis. This was followed by Europe contributing the second largest share to the eye infection treatment market with rising research and development. However, Asian countries are expected to be the fastest growing due to rising awareness, increasing personal care and hygiene, increasing rate of diagnostics, gradual adoption of improved technologies, increasing disposable income, and emerging health care infrastructures. Asia Pacific is followed by Latin America and Middle- East & Africa.  Increasing geriatric population is another factor that is expected to boost growth of the eye infection treatment market as the elderly population is at high risk of acquiring the infection. 

Some of the major players in the eye infection treatment market are Pfizer, Inc., Valeant Pharmaceuticals Inc., Novartis International AG., Johnson & Johnson, Bausch & Lomb, Inc., Bayer AG, GlaxoSmithKline plc. Merck & Co., Inc., Allergan Inc., and Alcon Laboratories Inc., among several other prominent players.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market    

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Eye Infection Treatment Market

Pre Book